APA (7th ed.) Citation

Fuentes-Antrás, J., Luna, A. d., Sá, A. L. d., Ocaña, A., García-Sáenz, J. Á., & Moreno, F. (2020). Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia. Elsevier.

Chicago Style (17th ed.) Citation

Fuentes-Antrás, Jesús, Alicia de Luna, Alfonso López de Sá, Alberto Ocaña, José Ángel García-Sáenz, and Fernando Moreno. Safety and Efficacy of Cyclin-dependent Kinase Inhibitor Rechallenge Following Ribociclib-induced Limiting Hypertransaminasemia. Elsevier, 2020.

MLA (8th ed.) Citation

Fuentes-Antrás, Jesús, et al. Safety and Efficacy of Cyclin-dependent Kinase Inhibitor Rechallenge Following Ribociclib-induced Limiting Hypertransaminasemia. Elsevier, 2020.